title: Pancreatitis and incretin-based drugs: clarity or confusion?
authors.affiliation: Diabeteszentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany.
authors.forename: Michael A
authors.initials: MA
authors.lastname: Nauck
authors.affiliation: Division of Diabetology and Gastrointestinal Endocrinology, St Josef-Hospital, University Hospital, Ruhr University, Bochum, Germany. Electronic address: nauck@diabeteszentrum.de.
authors.forename: Juris J
authors.initials: JJ
authors.lastname: Meier
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D054795:Incretins / Q000009:adverse effects*; D008297:Male; D010195:Pancreatitis / Q000139:chemically induced*
chemical_list: D007004:Hypoglycemic Agents; D054795:Incretins